Ari J Fried

Summary

Affiliation: Harvard University
Country: USA

Publications

  1. ncbi Pathogenesis, diagnosis, and management of primary antibody deficiencies and infections
    Ari J Fried
    Division of Immunology, Children s Hospital Boston, Fegan Building, 6th Floor, 300 Longwood Avenue, Boston, MA 02115, USA
    Clin Microbiol Rev 22:396-414. 2009
  2. ncbi Correlation of pneumococcal antibody concentration and avidity with patient clinical and immunologic characteristics
    Ari J Fried
    Division of Immunology, Boston Children s Hospital, Fegan 6, 300 Longwood Avenue, Boston, MA, 02115, USA
    J Clin Immunol 33:847-56. 2013
  3. ncbi Anti-IgE in the treatment of allergic disorders in pediatrics
    Ari J Fried
    Division of Immunology, Children s Hospital Boston, and Department of Pediatrics, Harvard Medical School, Boston, Massachusetts 02115, USA
    Curr Opin Pediatr 22:758-64. 2010

Collaborators

Detail Information

Publications3

  1. ncbi Pathogenesis, diagnosis, and management of primary antibody deficiencies and infections
    Ari J Fried
    Division of Immunology, Children s Hospital Boston, Fegan Building, 6th Floor, 300 Longwood Avenue, Boston, MA 02115, USA
    Clin Microbiol Rev 22:396-414. 2009
    ....
  2. ncbi Correlation of pneumococcal antibody concentration and avidity with patient clinical and immunologic characteristics
    Ari J Fried
    Division of Immunology, Boston Children s Hospital, Fegan 6, 300 Longwood Avenue, Boston, MA, 02115, USA
    J Clin Immunol 33:847-56. 2013
    ..Here we studied correlations of avidities and concentrations of antibodies to pneumococcal polysaccharides with immunologic and clinical characteristics of patients with recurrent infections...
  3. ncbi Anti-IgE in the treatment of allergic disorders in pediatrics
    Ari J Fried
    Division of Immunology, Children s Hospital Boston, and Department of Pediatrics, Harvard Medical School, Boston, Massachusetts 02115, USA
    Curr Opin Pediatr 22:758-64. 2010
    ..Findings of the most recent clinical trials of anti-IgE in the treatment of allergic disorders are discussed...